Self-assessment and objective determination of dexterity in patients with type 1 or type 2 diabetes mellitus

被引:12
|
作者
Pfuetzner, A. [1 ]
Musholt, P. B. [1 ]
Schipper, C. [1 ]
Niemeyer, M. [2 ]
Qvist, M. [2 ]
Schorsch, A. [1 ]
Forst, T. [1 ]
机构
[1] IKFE, Inst Clin Res & Dev, D-55116 Mainz, Germany
[2] NovoNordisk AB, Soborg, Denmark
关键词
Dexterity; Diabetes mellitus; Diabetes technology; Jebsen-Taylor hand function test; HAND FUNCTION; PSYCHOMOTOR FUNCTION; SENSORY NEUROPATHY; HEREDITARY MOTOR; MANUAL DEXTERITY; HYPOGLYCEMIA; RELIABILITY; LIMITATIONS;
D O I
10.1185/03007995.2011.638911
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Insulin-treated patients perform complex treatment activities during daily routine, such as blood glucose measurements and insulin injections. We aimed to identify suitable dexterity and cognitive function tests for diabetes patients, and to compare the patient self-assessment of their dexterity skills with the test results (Jebsen-Taylor hand function test, (JHFT), motoric performance test (MLS), number connection test). Method: We enrolled 90 diabetes patients (36 females, 54 males): 15 type 1 with clinically suspected dexterity impairment (A: age: 60 +/- 9 years), 30 type 2 with clinically suspected dexterity impairment (B: 61 +/- 10 years), 30 type 1 or type 2 patients with visual impairment (C: 64 +/- 6 years), and 15 type 1 or type 2 patients without obvious impairment (control group: D: 64 +/- 5 years). Results: There were no differences regarding neuropathy and slight impairments in the number connection test in all groups. Patient self-assessment revealed that 33.4% in group A, 33.3% in group B, 36.7% in group C and 13.7% in group D, considered themselves to have dexterity impairment. However in the JHFT test, all patients from A (100%) and B (100%), 33% from C, and 0% from D presented with dexterity impairment by only passing less than four subtests. Conclusions: Impairment of dexterity was much more frequent than believed by the patients themselves. It may be worthwhile to consider these findings when classifying patients regarding their capabilities to perform certain treatments or when assessing diabetes technology with human subjects.
引用
收藏
页码:15 / 21
页数:7
相关论文
共 50 条
  • [31] Comparison of Pharmacodynamics of Dapagliflozin in Patients with Type 1 or Type 2 Diabetes Mellitus
    Tang, Weifeng
    Bouw, Rene
    Johnsson, Eva
    Boulton, David W.
    Leil, Tarek A.
    Lacreta, Frank
    DIABETES, 2015, 64 : A303 - A303
  • [32] Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus
    Gudrun Leidig-Bruckner
    Sonja Grobholz
    Thomas Bruckner
    Christa Scheidt-Nave
    Peter Nawroth
    Jochen G Schneider
    BMC Endocrine Disorders, 14
  • [34] Prediction of risk of type 1 and type 2 diabetes postpartum in patients with gestational diabetes mellitus
    Fuechtenbusch, M.
    Ziegler, A. G.
    Hummel, M.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2006, 66 (10) : 947 - 951
  • [35] Determination of gliclazide minimum concentration in type 2 diabetes mellitus patients
    Czyrski, Andrzej
    Resztak, Matylda
    Hermann, Tadeusz
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 106 : 1267 - 1270
  • [36] Assessment of Growth and Final Height in Patients With Type 1 Diabetes Mellitus
    Coutinho, Claudia A.
    Calliari, Luis E.
    Noronha, Renata M.
    Kochi, Cristiane
    Monte, Osmar
    DIABETES, 2012, 61 : A332 - A332
  • [37] Assessment of cerebral metabolism in vivo in patients with type 1 diabetes mellitus
    Mankovsky, BN
    Rozhkova, ZZ
    Rogozin, VA
    Lipskaya, OE
    DIABETOLOGIA, 2001, 44 : A299 - A299
  • [38] Assessment of arterial stiffness in paediatric patients with type 1 diabetes mellitus
    Georeli, Eirini
    Stamati, Athina
    Dimitriadou, Meropi
    Chainoglou, Athanasia
    Tsinopoulou, Assimina Galli
    Stabouli, Stella
    Christoforidis, Athanasios
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2024, 38 (08)
  • [39] The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus
    Munir, Kashif M.
    Davis, Stephen N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (15) : 2331 - 2341
  • [40] THE QUALITY OF SELF-MANAGEMENT OF TYPE 2 DIABETES MELLITUS BY PATIENTS
    Bekbergenova, Z.
    Akhmetova, D.
    Zholdybay, A.
    Bazarbay, A.
    Issa, A.
    Kozhabayeva, N.
    Nurzhan, A.
    Azimberdi, B.
    Mergeneva, A.
    Salimova, A.
    Kalina, V
    VALUE IN HEALTH, 2020, 23 : S514 - S514